205 related articles for article (PubMed ID: 6410636)
21. Fine needle aspiration cytology of prostatic adenocarcinoma metastatic to the lung confirmed by the immunoperoxidase technique.
Bartziota EV
Acta Cytol; 1986; 30(5):497-500. PubMed ID: 2430390
[TBL] [Abstract][Full Text] [Related]
22. Immunoperoxidase staining of fine needle aspiration specimens previously stained by the Papanicolaou technique.
Travis WD; Wold LE
Acta Cytol; 1987; 31(4):517-20. PubMed ID: 2440215
[TBL] [Abstract][Full Text] [Related]
23. [Immunochemical approach to clinical cytology by demonstration of tumor markers using enzyme-labeled antibody technic].
Nishida K; Yamamoto T; Yoshioka K; Iida M; Miyagawa H; Yoshikawa T; Sugino S; Kondo M
Gan No Rinsho; 1986 Jul; 32(8):895-9. PubMed ID: 2427754
[TBL] [Abstract][Full Text] [Related]
24. Value of human chorionic gonadotropin compared to CEA in discriminating benign from malignant effusions.
Lamerz R; Stoetzer OJ; Mezger J; Brandt A; Darsow M; Wilmanns W
Anticancer Res; 1999; 19(4A):2421-5. PubMed ID: 10470169
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic value of three tumor markers determined in pleural effusions.
Conejo JR; Benedito JE; Jimenez A; Menchen M; Cano J; Granizo V; Larrodera L
Eur J Clin Chem Clin Biochem; 1996 Feb; 34(2):139-42. PubMed ID: 8833646
[TBL] [Abstract][Full Text] [Related]
26. Image analysis and flow cytometric DNA studies of benign and malignant body cavity fluids: reappraisal of the role of current methods in the differential diagnosis of reactive versus malignant conditions.
Lazcano O; Chen LM; Tsai C; Li CY; Katzmann JA; Sebo TJ; Kimlinger TK; Baker J
Mod Pathol; 2000 Jul; 13(7):788-96. PubMed ID: 10912939
[TBL] [Abstract][Full Text] [Related]
27. Use of a panel of markers in the differential diagnosis of adenocarcinoma and reactive mesothelial cells in fluid cytology.
Ko EC; Jhala NC; Shultz JJ; Chhieng DC
Am J Clin Pathol; 2001 Nov; 116(5):709-15. PubMed ID: 11710688
[TBL] [Abstract][Full Text] [Related]
28. Malignant ascites of serous papillary ovarian adenocarcinoma. An immunocytochemical study of the tumor cells.
Guzman J; Hilgarth M; Bross KJ; Ross A; Wiehle U; Kresin V; Grunert F; von Kleist S
Acta Cytol; 1988; 32(4):519-22. PubMed ID: 3041721
[TBL] [Abstract][Full Text] [Related]
29. The use of CDKN2A deletion as a diagnostic marker for malignant mesothelioma in body cavity effusions.
Illei PB; Ladanyi M; Rusch VW; Zakowski MF
Cancer; 2003 Feb; 99(1):51-6. PubMed ID: 12589646
[TBL] [Abstract][Full Text] [Related]
30. Immunoperoxidase detection of carcinoembryonic antigen in fine needle aspirates of breast carcinoma. Correlation with studies in tissue sections.
Murthy L; Kapila K; Verma K
Acta Cytol; 1988; 32(1):60-2. PubMed ID: 3276079
[TBL] [Abstract][Full Text] [Related]
31. Cytology of metastatic adenocarcinoma of the prostate in pleural effusions.
Renshaw AA; Nappi D; Cibas ES
Diagn Cytopathol; 1996 Aug; 15(2):103-7. PubMed ID: 8872430
[TBL] [Abstract][Full Text] [Related]
32. [Use of immunohistochemistry in clinical cytology].
Weintraub D; Weintraub J; Vassilakos P
Ann Pathol; 1987; 7(1):25-30. PubMed ID: 3304314
[TBL] [Abstract][Full Text] [Related]
33. Differentiating reactive mesothelial cells from metastatic adenocarcinoma in serous effusions: the utility of immunocytochemical panel in the differential diagnosis.
Saleh HA; El-Fakharany M; Makki H; Kadhim A; Masood S
Diagn Cytopathol; 2009 May; 37(5):324-32. PubMed ID: 19191294
[TBL] [Abstract][Full Text] [Related]
34. CEA, ZGM and EMA localization in cells of pleural and peritoneal effusion: a preliminary study.
O'Brien MJ; Kirkham SE; Burke B; Ormerod M; Saravis CA; Gottlieb LS; Neville AM; Zamcheck N
Invest Cell Pathol; 1980; 3(3):251-8. PubMed ID: 6159337
[TBL] [Abstract][Full Text] [Related]
35. Glypican-3 immunocytochemistry in liver fine-needle aspirates : a novel stain to assist in the differentiation of benign and malignant liver lesions.
Kandil D; Leiman G; Allegretta M; Trotman W; Pantanowitz L; Goulart R; Evans M
Cancer; 2007 Oct; 111(5):316-22. PubMed ID: 17763368
[TBL] [Abstract][Full Text] [Related]
36. [Carcinoembryonic antigen in ascites and pleural effusions].
Lirzin P; Zeitoun P; Vandromme L; Salas H
Gastroenterol Clin Biol; 1984 Mar; 8(3):222-7. PubMed ID: 6714557
[TBL] [Abstract][Full Text] [Related]
37. Peroxidase-labeled antibody staining for carcinoembryonic antigen of cytologic specimens for light and electron microscopy.
Osamura RY; Watanabe K; Akatsuka Y
Acta Cytol; 1985; 29(3):254-6. PubMed ID: 3890440
[TBL] [Abstract][Full Text] [Related]
38. Detection of tumor markers including carcinoembryonic antigen, APC, and cyclin D2 in fine-needle aspiration fluid of breast.
Lee A; Kim Y; Han K; Kang CS; Jeon HM; Shim SI
Arch Pathol Lab Med; 2004 Nov; 128(11):1251-6. PubMed ID: 15508191
[TBL] [Abstract][Full Text] [Related]
39. Fine catheter aspiration cytology of the peritoneal cavity in the diagnosis of a metastatic tumor. Report of a case with immunocytochemical studies.
Gupta RK; Prasad J; Stewart RJ
Acta Cytol; 1990; 34(3):434-6. PubMed ID: 2188472
[TBL] [Abstract][Full Text] [Related]
40. Immunocytochemical differentiation of reactive mesothelial cells and adenocarcinoma cells in serous effusions with the use of carcinoembryonic antigen and fibronectin.
Athanassiadou P; Athanassiades P; Lazaris D; Kyrkou K; Petrakakou E; Aravantinos D
Acta Cytol; 1994; 38(5):718-22. PubMed ID: 8091904
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
